bg-img9.jpg
8.jpg
[Video] Semi-Automated Biobanking: Delivering quality samples in less time

The holy grail in the biobanking industry is all about maximizing the value of biospecimens to deliver new therapies. Thus, there's now more pressure on biobanks to deliver samples that are in better condition, with better annotation, and with a more rapid turnaround time. In order to support our clients in achieving their aims in maximizing the value of their sample collections, we have installed a LiCONiC Semi-Automated Biobank (SAB) to manage the increased demands on sample utilization. To learn more and see the LiCONiC system in action, check out our video below!

Content: Video, Topic: Biobanking and Biorepositor..........

[Video] Understanding Risk: How to Manage High Value Biologics Part 2

In part one of this video series, I discussed the importance of risk management and some things to consider when entrusting external parties with your valued samples. For part two, let's explore some additional factors to include in your risk threat assessment and ways to not only protect your samples, but also protect your data!  

Content: Video, Topic: Biobanking and Biorepositor..........

[Video] Understanding Risk: How to Manage High Value Biologics Part 1

One of the things that I've learned that is very important to our clients and to our own organization is risk management. The management of risk is part of all business operations; however to those in the biotech industry that are manufacturing cell based therapies, risk mitigation is of utmost importance. The costly nature of your irreplaceable samples, valuable cell lines, and other high value product such as cell-based drugs, biologic active pharmaceutical ingredient (bio-API), dictates you and I to plan for the full continuum of risk. In this two-part video series, I'd like to share with you some of the questions you may ask yourself, or those you consider entrusting with your valued samples.

Content: Video, Topic: Biobanking and Biorepositor..........

[Video] Biorepository Services Help Discover Correlation Between DDT and Breast Cancer

DDT, once hailed as the miracle pesticide, was sprayed on crops, trees, and even inside houses throughout the United States in the 1950s and 60s. Though banned in 1972 and not used in the US for more than four decades, DDT has long been a suspect in the risk of breast cancer. New research shows that exposure, even from a long time ago, could be a contributing factor in the development of breast cancer; a connection scientists have been unable to make convincingly until now.

Courtesy of NBC Nightly News

Content: Video, Topic: Biobanking and Biorepositor..........

[Video] Standardize Your Sample and Temperature Management with CryoCradle™

Business today, no matter the industry, runs on innovation---it is one of the greatest features of being human to be able to constantly develop new technologies. Sometimes, the established techniques have been in practice for decades, and haven't been substantially modified for any number of reasons: any improvements are too insignificant to notice, changes would require an as-of-yet undeveloped ancillary technology, or the technique already has such considerable efficiency that we can become complacent.

Content: Video, Topic: Biobanking and Biorepositor..........

[Video] Delivering Your Cell Therapy: Getting Reliable Performance from Dry Shippers

A cell therapy clinical trial can fail for any number of reasons many of which are unavoidable. Many of these failures can be avoided by understanding the basic laws of nature and taking appropriate action to eliminate or minimize their effect.

Content: Video, Topic: Cell Therapy Solutions

[Video] The Journey of a Sample... in the Biobank Laboratory

So much depends on the subtle variations in biospecimens: these variations, when analyzed via genomics, proteomics, metabolomics, and similar studies, are the foundation of both disease-based and drug-based biomarker discovery. And if the unique "-omics" of a sample is to yield results that lead to improvements in medical research and healthcare, such as understanding disease cause/progression (predictive/prognostic biomarker) to PK/PD in clinical trials (surrogate endpoints), then the entire integrity of the specimen must be protected, or biomarker research/study can go astray. 

Content: Video, Topic: Laboratory Processing

[Video] Sample Collection for Clinical Trials & Longitudinal Studies: Bulk Supplies VS. Collection Kits

When setting up a clinical trial or a longitudinal study, every decision revolving around sample management: collection, lab processing, storage, disssemination, and data management, is crucial to its success. For collection of clinical participants' biospecimens, one aspect that requires significant thought and planning is how the needed patient samples (e.g. whole blood, tissue) will be collected at the clinical sites.  Sponsors, CROs, and clinical investigators must decide if they are going to provide their sites with the tubes and other supplies in bulk, or provide patient-specific or visit-specific collection kits.  Below are five points to consider when making your decision:  

Content: Video, Topic: Kit Production